8-(3-chlorophenoxy)-3-(1-(4-chlorophenyl)cyclopropyl)-[1,2,4]triazolo[4,3-a]pyridine | 1610951-54-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 8-(3-chlorophenoxy)-3-(1-(4-chlorophenyl)cyclopropyl)-[1,2,4]triazolo[4,3-a]pyridine
• 英文别名: 8-(3-Chlorophenoxy)-3-[1-(4-chlorophenyl)cyclopropyl]-[1,2,4]triazolo[4,3-a]pyridine
• CAS: 1610951-54-6
• 化学式: C₂₁H₁₅Cl₂N₃O
• 分子量: 396.276
• InChiKey: MWCQWYCYOKYQII-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.2
• 重原子数：
  27
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  39.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  3-溴-2-氯吡啶 在 N-甲基吗啉 、 四氯化碳 、 caesium carbonate 、 N,N-二异丙基乙胺 、 三苯基膦 、 肼 、 氯甲酸异丁酯 作用下， 以 四氢呋喃 、 1,4-二氧六环 为溶剂， 反应 34.59h， 生成 8-(3-chlorophenoxy)-3-(1-(4-chlorophenyl)cyclopropyl)-[1,2,4]triazolo[4,3-a]pyridine
  参考文献：
  名称：

  Optimization of 1,2,4-Triazolopyridines as Inhibitors of Human 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD-1)

  摘要：

  Small alkyl groups and spirocyclic-aromatic rings directly attached to the left side and right side of the 1,2,4-triazolopyridines (TZP), respectively, were found to be potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase-type 1 (11β-HSD-1) enzyme. 3-(1-(4-Chlorophenyl)cyclopropyl)-8-cyclopropyl-[1,2,4]triazolo[4,3-a]pyridine (9f) was identified as a potent inhibitor of the 11β-HSD-1 enzyme with reduced Pregnane-X receptor (PXR) transactivation activity. The binding orientation of this TZP series was revealed by X-ray crystallography structure studies.

  DOI：

  10.1021/ml500144h

文献信息

• TRIAZOLOPYRIDINE 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS
  申请人：Li James J.

  公开号：US20090203668A1

  公开（公告）日：2009-08-13

  Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure: or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof wherein W, L, R 3 , R 3a , R 3b and R 4 are defined herein.

  提供了新型化合物，它们是11-β-羟基类固醇脱氢酶I型抑制剂。11-β-羟基类固醇脱氢酶I型抑制剂在治疗、预防或减缓需要11-β-羟基类固醇脱氢酶I型抑制剂治疗的疾病方面是有用的。这些新型化合物具有以下结构：或其立体异构体或前药或其药学上可接受的盐，其中W、L、R3、R3a、R3b和R4在此定义。
• US7579360B2
  申请人：——

  公开号：US7579360B2

  公开（公告）日：2009-08-25
• US8148396B2
  申请人：——

  公开号：US8148396B2

  公开（公告）日：2012-04-03
• Optimization of 1,2,4-Triazolopyridines as Inhibitors of Human 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD-1)
  作者：Jun Li、Lawrence J. Kennedy、Haixia Wang、James J. Li、Steven J. Walker、Zhenqiu Hong、Stephen P. O’Connor、Akbar Nayeem、Daniel M. Camac、Paul E. Morin、Steven Sheriff、Mengmeng Wang、Timothy Harper、Rajasree Golla、Ramakrishna Seethala、Thomas Harrity、Randolph P. Ponticiello、Nathan N. Morgan、Joseph R. Taylor、Rachel Zebo、David A. Gordon、Jeffrey A. Robl

  DOI：10.1021/ml500144h

  日期：2014.7.10

  Small alkyl groups and spirocyclic-aromatic rings directly attached to the left side and right side of the 1,2,4-triazolopyridines (TZP), respectively, were found to be potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase-type 1 (11β-HSD-1) enzyme. 3-(1-(4-Chlorophenyl)cyclopropyl)-8-cyclopropyl-[1,2,4]triazolo[4,3-a]pyridine (9f) was identified as a potent inhibitor of the 11β-HSD-1 enzyme with reduced Pregnane-X receptor (PXR) transactivation activity. The binding orientation of this TZP series was revealed by X-ray crystallography structure studies.